Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
Journal of the National Cancer Institute
|
April 22, 2016
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial
Amir Sonnenblick, Evandro de Azambuja, Dominique Agbor-Tarh, et al.
JAMA Oncology
|
December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence
Michail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.
Cancer Research Communications
|
October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors
Marc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.
Breast (Edinburgh, Scotland)
|
February 14, 2026
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis
Luca Arecco, Pedro M Cacilhas, Camila Bobato Lara Gismondi, et al.
Breast (Edinburgh, Scotland)
|
September 25, 2013
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial
Hatem A Azim, Francoise Rothé, Claudia Monica Aura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, et al.
Breast (Edinburgh, Scotland)
|
February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?
Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2019
Lucitanib for the Treatment of HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study
Rina Hui, Alex Pearson, Javier Cortes, et al.
JAMA Oncology
|
September 30, 2016
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial
Debora Fumagalli, David Venet, Michail Ignatiadis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis
Matteo Lambertini, Eva Blondeaux, Marco Bruzzone, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
Journal of the National Cancer Institute
|
April 22, 2016
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial
Amir Sonnenblick, Evandro de Azambuja, Dominique Agbor-Tarh, et al.
JAMA Oncology
|
December 4, 2015
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence
Michail Ignatiadis, Hatem A Azim, Christine Desmedt, et al.
Cancer Research Communications
|
October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors
Marc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.
Breast (Edinburgh, Scotland)
|
February 14, 2026
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis
Luca Arecco, Pedro M Cacilhas, Camila Bobato Lara Gismondi, et al.
Breast (Edinburgh, Scotland)
|
September 25, 2013
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial
Hatem A Azim, Francoise Rothé, Claudia Monica Aura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, et al.
Breast (Edinburgh, Scotland)
|
February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?
Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2019
Lucitanib for the Treatment of HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study
Rina Hui, Alex Pearson, Javier Cortes, et al.
JAMA Oncology
|
September 30, 2016
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial
Debora Fumagalli, David Venet, Michail Ignatiadis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis
Matteo Lambertini, Eva Blondeaux, Marco Bruzzone, et al.
Page
of 14